United States Biotechnology & Medical Research

GlobeStar Therapeutics Corp (GSTC)

Track

Ticker: GSTC Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Atwood Brent Large shareholder
Transaction date
Purchase
Price
477.73
Quantity 86,786 +37.8%
Value US$3,560,125
Atwood Brent Large shareholder
Transaction date
Purchase
Price
442.03
Quantity 62,459 +48.7%
Value US$4,268,202
Atwood Brent Large shareholder
Transaction date
Purchase
Price
482.25
Quantity 6,893 +25.5%
Value US$890,691
Atwood Brent Large shareholder
Transaction date
Purchase
Price
0.02
Quantity 750,000 +75.0%
Value US$15,000
Atwood Brent Large shareholder
Transaction date
Purchase
Price
0.02
Quantity 500,000 +28.6%
Value US$10,000
Atwood Brent Large shareholder
Transaction date
Purchase
Price
0.02
Quantity 1,099,531 +37.9%
Value US$21,991
Atwood Brent Large shareholder
Transaction date
Purchase
Price
0.02
Quantity 4,000,000 +inf%
Value US$80,000
Atwood Brent Large shareholder
Transaction date
Purchase
Price
0.02
Quantity 2,500,000 +inf%
Value US$50,000
Atwood Brent Large shareholder
Transaction date
Purchase
Price
0.02
Quantity 1,750,000 +inf%
Value US$35,000
Blankenship Alex K CEO, Pres., Secr., Treas. Executive Director
Transaction date
Purchase
Price
0.00
Quantity 3,500,000
Value US$0
Blankenship Alex K CEO, Pres., Secr., Treas. Executive Director
Transaction date
Purchase
Price
0.00
Quantity 500,000
Value US$0
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-08-15 2019-08-14 B Purchase Atwood Brent Large shareholder
86,786 +37.8%
477.73
US$3,560,125 		86,786 +37.8% 477.73 US$3,560,125
2019-08-15 2019-08-14 B Purchase Atwood Brent Large shareholder
62,459 +48.7%
442.03
US$4,268,202 		62,459 +48.7% 442.03 US$4,268,202
2019-08-15 2019-08-14 B Purchase Atwood Brent Large shareholder
6,893 +25.5%
482.25
US$890,691 		6,893 +25.5% 482.25 US$890,691
2019-08-15 2019-08-14 B Purchase Atwood Brent Large shareholder
750,000 +75.0%
0.02
US$15,000 		750,000 +75.0% 0.02 US$15,000
2019-08-15 2019-08-14 B Purchase Atwood Brent Large shareholder
500,000 +28.6%
0.02
US$10,000 		500,000 +28.6% 0.02 US$10,000
2019-08-15 2019-08-13 B Purchase Atwood Brent Large shareholder
1,099,531 +37.9%
0.02
US$21,991 		1,099,531 +37.9% 0.02 US$21,991
2019-08-15 2019-08-13 B Purchase Atwood Brent Large shareholder
4,000,000 +inf%
0.02
US$80,000 		4,000,000 +inf% 0.02 US$80,000
2019-08-15 2019-08-13 B Purchase Atwood Brent Large shareholder
2,500,000 +inf%
0.02
US$50,000 		2,500,000 +inf% 0.02 US$50,000
2019-08-15 2019-08-13 B Purchase Atwood Brent Large shareholder
1,750,000 +inf%
0.02
US$35,000 		1,750,000 +inf% 0.02 US$35,000
2018-12-11 2018-12-06 B Purchase
Blankenship Alex K

CEO, Pres., Secr., Treas.

Executive Director
3,500,000
0.00
US$0 		3,500,000 0.00 US$0
2017-06-08 2017-04-07 B Purchase
Blankenship Alex K

CEO, Pres., Secr., Treas.

Executive Director
500,000
0.00
US$0 		500,000 0.00 US$0
Explore more

More insider trading research around GlobeStar Therapeutics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America